These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 14532267

  • 21. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST, Swanson R, Raub-Segall E, Bedsted T, Sadri M, Petitou M, Hérault JP, Herbert JM, Björk I.
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [Abstract] [Full Text] [Related]

  • 22. Heparin-activated antithrombin interacts with the autolysis loop of target coagulation proteases.
    Yang L, Manithody C, Rezaie AR.
    Blood; 2004 Sep 15; 104(6):1753-9. PubMed ID: 15178583
    [Abstract] [Full Text] [Related]

  • 23. Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.
    Yang L, Manithody C, Qureshi SH, Rezaie AR.
    Thromb Haemost; 2010 Feb 15; 103(2):277-83. PubMed ID: 20024502
    [Abstract] [Full Text] [Related]

  • 24. The role of the COOH-terminal region of antithrombin III. Evidence that the COOH-terminal region of the inhibitor enhances the reactivity of thrombin and factor Xa with the inhibitor.
    Nishioka J, Suzuki K.
    J Biol Chem; 1992 Nov 05; 267(31):22224-9. PubMed ID: 1331047
    [Abstract] [Full Text] [Related]

  • 25. Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin.
    Desai UR, Petitou M, Björk I, Olson ST.
    J Biol Chem; 1998 Mar 27; 273(13):7478-87. PubMed ID: 9516447
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Role of the P6-P3' region of the serpin reactive loop in the formation and breakdown of the inhibitory complex.
    Plotnick MI, Schechter NM, Wang ZM, Liu X, Rubin H.
    Biochemistry; 1997 Nov 25; 36(47):14601-8. PubMed ID: 9398179
    [Abstract] [Full Text] [Related]

  • 28. Protease specificity and heparin binding and activation of recombinant protease nexin I.
    Evans DL, McGrogan M, Scott RW, Carrell RW.
    J Biol Chem; 1991 Nov 25; 266(33):22307-12. PubMed ID: 1939253
    [Abstract] [Full Text] [Related]

  • 29. Specificity of the basic side chains of Lys114, Lys125, and Arg129 of antithrombin in heparin binding.
    Schedin-Weiss S, Arocas V, Bock SC, Olson ST, Björk I.
    Biochemistry; 2002 Oct 15; 41(41):12369-76. PubMed ID: 12369826
    [Abstract] [Full Text] [Related]

  • 30. Probing the molecular basis of factor Xa specificity by mutagenesis of the serpin, antithrombin.
    Rezaie AR, Yang L.
    Biochim Biophys Acta; 2001 Oct 03; 1528(2-3):167-76. PubMed ID: 11687304
    [Abstract] [Full Text] [Related]

  • 31. Serine 380 (P14) --> glutamate mutation activates antithrombin as an inhibitor of factor Xa.
    Futamura A, Gettins PG.
    J Biol Chem; 2000 Feb 11; 275(6):4092-8. PubMed ID: 10660568
    [Abstract] [Full Text] [Related]

  • 32. Selective disruption of heparin and antithrombin-mediated regulation of human factor IX.
    Westmark PR, Tanratana P, Sheehan JP.
    J Thromb Haemost; 2015 Jun 11; 13(6):1053-63. PubMed ID: 25851619
    [Abstract] [Full Text] [Related]

  • 33. Mechanisms responsible for catalysis of the inhibition of factor Xa or thrombin by antithrombin using a covalent antithrombin-heparin complex.
    Paredes N, Wang A, Berry LR, Smith LJ, Stafford AR, Weitz JI, Chan AK.
    J Biol Chem; 2003 Jun 27; 278(26):23398-409. PubMed ID: 12695507
    [Abstract] [Full Text] [Related]

  • 34. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA, Gettins PG.
    Biochemistry; 1998 Mar 10; 37(10):3272-7. PubMed ID: 9521646
    [Abstract] [Full Text] [Related]

  • 35. Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the heparin-antithrombin complex.
    Rezaie AR.
    Blood; 2001 Apr 15; 97(8):2308-13. PubMed ID: 11290592
    [Abstract] [Full Text] [Related]

  • 36. Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism.
    Buyue Y, Misenheimer TM, Sheehan JP.
    J Thromb Haemost; 2012 Oct 15; 10(10):2086-98. PubMed ID: 22905983
    [Abstract] [Full Text] [Related]

  • 37. The oligosaccharide side chain on Asn-135 of alpha-antithrombin, absent in beta-antithrombin, decreases the heparin affinity of the inhibitor by affecting the heparin-induced conformational change.
    Turk B, Brieditis I, Bock SC, Olson ST, Björk I.
    Biochemistry; 1997 Jun 03; 36(22):6682-91. PubMed ID: 9184148
    [Abstract] [Full Text] [Related]

  • 38. Role of the residues of the 39-loop in determining the substrate and inhibitor specificity of factor IXa.
    Yang L, Manithody C, Qureshi SH, Rezaie AR.
    J Biol Chem; 2010 Sep 10; 285(37):28488-95. PubMed ID: 20628058
    [Abstract] [Full Text] [Related]

  • 39. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
    Jordan RE, Oosta GM, Gardner WT, Rosenberg RD.
    J Biol Chem; 1980 Nov 10; 255(21):10081-90. PubMed ID: 6448846
    [Abstract] [Full Text] [Related]

  • 40. A common protein C inhibitor exosite partially controls the heparin induced activation and inhibition of serine proteases.
    Siddiqui U, Khan AB, Ahmad T, Rehman AA, Jairajpuri MA.
    Int J Biol Macromol; 2024 May 10; 266(Pt 2):131065. PubMed ID: 38521329
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.